Head to Head

ALSN vs UROY: which is the better buy in 2026?

Allison Transmission Holdings, Inc.

NYSE:ALSN

82/100 Compass
True NorthAccumulate$9.6B

Boring transmission maker just bought itself into a $2B off-highway franchise, and the market is still pricing it like a truck cycle bet.

Full ALSN analysis

Uranium Royalty Corp.

NASDAQ:UROY

82/100 Compass
True NorthAccumulate$540M

The only pure-play uranium royalty vehicle, levered to a price cycle that's still in its early innings with zero capex drag.

Full UROY analysis

Factor by factor

FactorALSNUROY
Revenue Growth9898
Profitability6337
Valuation7143
Momentum6339
Theme Purity4562
Moat4845
Catalysts5572
Market Position5050

Get head-to-heads like this, free

Join the Alexandria e-letter for Compass verdicts, earnings intelligence, and the contrarian calls the crowd misses. Twice a week, no noise.

Free forever. Unsubscribe anytime. We never share your email.

Frequently asked questions

Is ALSN or UROY the better buy in 2026?

ALSN and UROY are neck and neck at 82/100 on the Compass right now. The better fit depends on which factors matter most to you.

How does Alexandria compare ALSN and UROY?

Each company is scored 1-100 on eight factors: revenue growth, profitability, valuation, momentum, theme purity, moat, catalysts, and market position. The Compass Score is the composite, and the comparison below shows where each name wins factor by factor.

Compass Scores are proprietary editorial research from publicly available data, not investment advice or a recommendation regarding any security. Rankings update weekly.